According to BridgeBio Pharma
's latest financial reports the company's current revenue (TTM ) is โน18.85 Billion. In 2023 the company made a revenue of โน0.77 Billion a decrease over the revenue in the year 2022 that were of โน6.42 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | โน18.15 B | 2244.67% |
2023 | โน0.77 B | -87.95% |
2022 | โน6.42 B | 23.83% |
2021 | โน5.18 B | 760.14% |
2020 | โน0.60 B | -79.14% |
2019 | โน2.89 B | |
2018 | N/A |